European Archives - Page 35 of 1218 - European Medical Journal

Advancing Frontiers in Myeloproliferative Neoplasms

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…

Lenzilumab and Azacitidine Combination Therapy in Proliferative CMML

Chronic myelomonocytic leukaemia (CMML) is a rare cancer orchestrated by granulocyte-macrophage colony-stimulating factor (GM-CSF)…

MRD in Clinical and Regulatory Decisions

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…

Vitamin K-Dependent Bleeding Linked to Topiramate

Topiramate is a well-known medication used for migraine and epilepsy. Bleeding is a rare and less documented side-effect of this treatment…

Evolving Endpoint Strategies

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…

Single HPV Vaccine Dose in Girls Shows Strong Long-Term Immunity

New data show that one dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose course in adult women.

Circulating Tumour DNA Predicts Melanoma Recurrence Risk

Gene expression analysis also revealed that increased Myc-related gene expression correlated with poorer outcomes.

EMJ Rheumatology 12.1 2025

Inside, you can explore a wide range of content, including our in-depth review of the EULAR 2025 Congress, exclusive interviews with experts…

How to Treat GCA in 2025

Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis in adults, involving medium-to-large-sized vessels. It occurs…

MOv18 IgE and Non-Allergic Skin Reactions in AllergoOncology

MOv18 IgE is a first-in-class IgE antibody targeting FRα, an antigen overexpressed in ovarian and other cancers…